$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth

$jfth Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000159991623000177 Filed on August 16, 2023

Income Statement

Concept	2023	2022
Revenue	$1.000K	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit	$1.038K
YoY Change
Gross Profit Margin	103.8%
Selling, General & Admin		$1.047M
YoY Change
% of Gross Profit
Research & Development	$66.42K
YoY Change
% of Gross Profit	6399.04%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$326.4K	$1.047M
YoY Change	-68.83%
Operating Profit	-$325.4K	-$1.047M
YoY Change	-68.93%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$1.047M
YoY Change
Income Tax	-$774.00
% Of Pretax Income
Net Earnings	-$321.8K	-$1.047M
YoY Change	-69.27%
Net Earnings / Revenue	-32182.0%
Basic Earnings Per Share	-$0.03	-$0.10
Diluted Earnings Per Share		-$488.40
COMMON SHARES
Basic Shares Outstanding	12.85M shares	10.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.365K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$542.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$542.2K
Total Long-Term Assets	$0.00
Total Assets	$542.2K	$0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.396K
YoY Change
Accrued Expenses	$2.705K	$7.000K
YoY Change	-61.36%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$7.000K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$7.000K
Total Long-Term Liabilities		$0.00
Total Liabilities	$40.12K	$7.000K
YoY Change	473.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.375M
YoY Change	30.57%
Common Stock	$1.312K
YoY Change	-99.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$502.1K	-$7.000K
YoY Change
Total Liabilities & Shareholders Equity	$542.2K	$0.00
YoY Change

Cashflow Statement

Concept	2023	2022
OPERATING ACTIVITIES
Net Income	-$321.8K	-$1.047M
YoY Change	-69.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$293.6K	-$43.86K
YoY Change	569.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$527.7K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$854.6K	43.86K
YoY Change	1848.38%
NET CHANGE
Cash From Operating Activities	-$293.6K	-43.86K
Cash From Investing Activities	-$527.7K
Cash From Financing Activities	$854.6K	43.86K
Net Change In Cash	$1.365K	0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$293.6K	-$43.86K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001857910
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2022Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent		usd
CY2022Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases		usd
CY2022Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties		usd
CY2022Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent		usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent		usd
CY2022Q1	us-gaap	Assets Assets		usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2022Q1	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment		usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties		usd
CY2022	DRFS	Totalrevenues Totalrevenues		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2022	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding		shares
CY2022	DRFS	Stock And Warrants Issuedcommonstock StockAndWarrantsIssuedcommonstock		usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
CY2022	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable		usd
CY2022	DRFS	Advancepayments Advancepayments		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2022	DRFS	Accountspayableother Accountspayableother		usd
CY2022	DRFS	Interestreceivableperiod Interestreceivableperiod		usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2022	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease		usd
CY2022	DRFS	Paymentsreceivedfromrelatedpartyloan Paymentsreceivedfromrelatedpartyloan		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	DRFS	Cashreceivedforcommonshares Cashreceivedforcommonshares		usd
CY2022	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash		usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	false
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Entity File Number EntityFileNumber	000-5627
CY2023	dei	Entity Registrant Name EntityRegistrantName	Dr. Foods, Inc.
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	6367034	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13708699	shares
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Location AuditorLocation	Houston, TX
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1365	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	384	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	567	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	535460	usd
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	4402	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	542178	usd
CY2023Q1	us-gaap	Assets Assets	542178	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7396	usd
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	29524	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2705	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	497	usd
CY2023Q1	us-gaap	Liabilities Liabilities	40122	usd
CY2022Q1	us-gaap	Liabilities Liabilities	7000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4800000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11576427	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1312	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	1158	usd
CY2023Q1	DRFS	Foreigncurrencytranslationadjustment Foreigncurrencytranslationadjustment	-23683	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1899114	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1044709	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1374688	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1052868	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	502056	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	542178	usd
CY2023	us-gaap	Revenues Revenues	1000	usd
CY2023	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	38	usd
CY2023	DRFS	Totalrevenues Totalrevenues	1038	usd
CY2023	us-gaap	Gross Profit GrossProfit	1038	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	326423	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1047108	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	326423	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1047108	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-325385	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1047108	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	4339	usd
CY2023	DRFS	Interest And Other Incometotal InterestAndOtherIncometotal	4339	usd
CY2023	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-321046	usd
CY2022	DRFS	Netincomelossbeforetax Netincomelossbeforetax	-1047108	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-774	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1047108	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-23683	usd
CY2023	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-345503	usd
CY2022	DRFS	Total Comprehensive Income Loss Tax TotalComprehensiveIncomeLossTax	-1047108	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12853560	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10720089	shares
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3750	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1000000	usd
CY2022	DRFS	Proceeds From Contributions ProceedsFromContributions	43858	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1047108	usd
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11576427	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7000	usd
CY2023	DRFS	Common Stock Shares Subscriptions Sold CommonStockSharesSubscriptionsSold	769231	usd
CY2023	DRFS	Proceeds From Contributions ProceedsFromContributions	67574	usd
CY2023	DRFS	Capitalcontributedbysub Capitalcontributedbysub	17754	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-23683	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	502056	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-321820	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1047108	usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	1000000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-379	usd
CY2023	DRFS	Advancepayments Advancepayments	-558	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	29692	usd
CY2023	DRFS	Accountspayableother Accountspayableother	7504	usd
CY2023	DRFS	Interestreceivableperiod Interestreceivableperiod	-4338	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4234	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3250	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	505	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-293628	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-48858	usd
CY2023	DRFS	Loantorelatedpartyincreasedecrease Loantorelatedpartyincreasedecrease	-710700	usd
CY2023	DRFS	Paymentsreceivedfromrelatedpartyloan Paymentsreceivedfromrelatedpartyloan	183025	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-527675	usd
CY2023	DRFS	Cashreceivedforcommonshares Cashreceivedforcommonshares	769231	usd
CY2023	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	85328	usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	43858	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	854559	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43858	usd
CY2023	DRFS	Neteffectofexchangeratechangesoncash Neteffectofexchangeratechangesoncash	-31891	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1365	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1365	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zieCUxba9dW1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_867_z1vAQTYFNAO8" style="font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary to make the financial statements not misleading have been included. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 10pt"> </span></p>
CY2023Q1	DRFS	Netlossasof Netlossasof	1374688	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	288684	usd
CY2023	DRFS	Companydeferredtaxassets Companydeferredtaxassets	<p id="xdx_89B_ecustom--Companydeferredtaxassets_zzfAACgYXM68" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">Significant components of <span id="xdx_8B2_zmGXUNkVajvg">the Company’s deferred tax assets</span> are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="5" style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31,</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="5" style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax asset, generated from net operating loss</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,684</span><span style="font-size: 8pt"> </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,102</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (288,684)</span><span style="font-size: 8pt"> </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(222,102)</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">— </span></td> <td style="vertical-align: top; text-align: center; line-height: 11.65pt"> </td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="vertical-align: bottom; text-align: center; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="vertical-align: bottom; line-height: 11.65pt"> </td></tr> </table>
CY2023	DRFS	Reconciliationofeffectiveincometaxrate Reconciliationofeffectiveincometaxrate	<p id="xdx_893_ecustom--Reconciliationofeffectiveincometaxrate_z2zu7j11ACyl" style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">T<span id="xdx_8B8_zkx8qcTMGbw5">he reconciliation of the effective income tax rate to the federal statutory rate</span> is as follows:</span></p> <p style="font: 10pt/10.5pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; background-color: white"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 92%; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal income tax rate 21.0%</span></td> <td style="width: 1%; line-height: 11.65pt"> </td> <td style="width: 1%; line-height: 11.65pt"> </td> <td style="width: 5%; text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.0</span></td> <td style="width: 1%; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span><span style="font-size: 8pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase in valuation allowance (21.0%)</span></td> <td style="line-height: 11.65pt"> </td> <td style="line-height: 11.65pt"> </td> <td style="text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.0</span></td> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective income tax rate 0.0%</span></td> <td style="line-height: 11.65pt"> </td> <td style="line-height: 11.65pt"> </td> <td style="text-align: right; line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0</span></td> <td style="line-height: 11.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table>
CY2023Q1	DRFS	Preferredauthasof Preferredauthasof	20000000	shares
CY2023Q1	DRFS	Preferredsharesparvalueasof Preferredsharesparvalueasof	0.0001	usd
CY2023Q1	DRFS	Preferredsharesasof Preferredsharesasof	10000	shares
CY2023Q1	DRFS	Commonsharesauthorizedasof Commonsharesauthorizedasof	4800000000	shares
CY2023Q1	DRFS	Commonparvalueasof Commonparvalueasof	0.0001	usd
CY2023Q1	DRFS	Commonsharesoutstandingasof Commonsharesoutstandingasof	13114888	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13114888	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11576427	shares
CY2023	DRFS	Expensespaidbyofficerduringyear Expensespaidbyofficerduringyear	85328	usd
CY2022	DRFS	Expensespaidbyofficerduringyear Expensespaidbyofficerduringyear	36758	usd
CY2022	DRFS	Expensespaidbyformerofficerduringyear Expensespaidbyformerofficerduringyear	7100	usd
CY2023	DRFS	Loanedtowhiteknightco Loanedtowhiteknightco	721186	usd
CY2023	DRFS	Expensesinvoiced Expensesinvoiced	29524	usd
CY2023	DRFS	Expensespaidbywhollyownedsub Expensespaidbywhollyownedsub	67574	usd
CY2023Q2	DRFS	Paidbyultimateonellc Paidbyultimateonellc	187050	usd

Files In Submission

Name	View Source	Status
0001599916-23-000177-index-headers.html	Edgar Link	pending
0001599916-23-000177-index.html	Edgar Link	pending
0001599916-23-000177.txt	Edgar Link	pending
0001599916-23-000177-xbrl.zip	Edgar Link	pending
drfs-20230331.xsd	Edgar Link	pending
drfs_10k23o.htm	Edgar Link	pending
exhibit31.htm	Edgar Link	pending
exhibit32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_020.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
drfs-20230331_def.xml	Edgar Link	unprocessable
drfs-20230331_cal.xml	Edgar Link	unprocessable
drfs-20230331_pre.xml	Edgar Link	unprocessable
drfs-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
drfs_10k23o_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth

2023 Q1 Form 10-K Financial Statement

#000159991623000177 Filed on August 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH Japan Food Tech Holdings, Inc. Stock $jfth

2023 Q1 Form 10-K Financial Statement

#000159991623000177 Filed on August 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JFTH
Japan Food Tech Holdings, Inc. Stock $jfth